{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:54:24Z","timestamp":1790988864196,"version":"4.1.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/hjh.0b013e32833d0177","type":"journal-article","created":{"date-parts":[[2010,7,30]],"date-time":"2010-07-30T05:53:12Z","timestamp":1280469192000},"page":"2120-2126","source":"Crossref","is-referenced-by-count":75,"title":["Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients"],"prefix":"10.1097","volume":"28","author":[{"given":"Carlos B","family":"Stehr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie","family":"Mellado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P","family":"Ocaranza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian A","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Mosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Becerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Solis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Lavandero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Jalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E","family":"Fardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20210208","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0039-128X(94)00026-9","article-title":"Aldosterone biosynthesis and action in vascular cells","volume":"60","author":"Takeda","year":"1995","journal-title":"Steroids"},{"key":"R2-21-20210208","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary hyperaldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R3-21-20210208","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1006\/jmcc.2000.1129","article-title":"Induction of cardiac fibrosis by aldosterone","volume":"6","author":"Lijnen","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"R4-21-20210208","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.HYP.0000023182.68420.EB","article-title":"Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism","volume":"40","author":"Rossi","year":"2002","journal-title":"Hypertension"},{"key":"R5-21-20210208","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/HYPERTENSIONAHA.108.114140","article-title":"Inappropriate left ventricular mass in patients with primary aldosteronism","volume":"52","author":"Muiesan","year":"2008","journal-title":"Hypertension"},{"key":"R6-21-20210208","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"R7-21-20210208","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"R8-21-20210208","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.106.649939","article-title":"Prognostic significance of the centers for disease control\/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease","volume":"115","author":"Sabatine","year":"2007","journal-title":"Circulation"},{"key":"R9-21-20210208","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/01.RES.81.3.448","article-title":"Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?","volume":"81","author":"Sch\u00f6nbeck","year":"1997","journal-title":"Circ Res"},{"key":"R10-21-20210208","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1373\/clinchem.2007.097360","article-title":"Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction","volume":"54","author":"Packard","year":"2008","journal-title":"Clin Chem"},{"key":"R11-21-20210208","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","article-title":"Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease","volume":"107","author":"Blankenberg","year":"2003","journal-title":"Circulation"},{"key":"R12-21-20210208","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.amjhyper.2005.08.019","article-title":"Plasma osteopontin levels are higher in patients with primary aldosteronism than in patients with essential hypertension","volume":"19","author":"Irita","year":"2006","journal-title":"Am J Hypertens"},{"key":"R13-21-20210208","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMra0800239","article-title":"Biomarkers in heart failure","volume":"358","author":"Braunwald","year":"2008","journal-title":"N Engl J Med"},{"key":"R14-21-20210208","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/HYPERTENSIONAHA.107.095489","article-title":"Aldosterone and vascular inflammation","volume":"51","author":"Brown","year":"2008","journal-title":"Hypertension"},{"key":"R15-21-20210208","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/HCO.0b013e3281ca710d","article-title":"Endothelial function and hypertension","volume":"22","author":"Landmesser","year":"2007","journal-title":"Curr Opin Cardiol"},{"key":"R16-21-20210208","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.metabol.2007.01.011","article-title":"Elevated matrix metalloproteinase 9 and tissue inhibitors of metalloproteinase 1 in obese children and adolescents","volume":"56","author":"Glowinska-Olszewska","year":"2007","journal-title":"Metabolism"},{"key":"R17-21-20210208","first-page":"893","article-title":"Mineralocorticoid excess, dietary sodium and myocardial fibrosis","volume":"120","author":"Brilla","year":"1992","journal-title":"J Lab Clin Med"},{"key":"R18-21-20210208","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1172\/JCI117269","article-title":"Mineralocorticoids, hypertension and cardiac fibrosis","volume":"93","author":"Young","year":"1994","journal-title":"J Clin Invest"},{"key":"R19-21-20210208","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0895-7061(03)00052-9","article-title":"Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild to moderate arterial hypertension","volume":"16","author":"Rajzer","year":"2003","journal-title":"Am J Hypertens"},{"key":"R20-21-20210208","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/path.1395","article-title":"The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis","volume":"200","author":"Heeneman","year":"2003","journal-title":"J Pathol"},{"key":"R21-21-20210208","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cardfail.2004.01.010","article-title":"Independent and additional prognostic value of amino-terminal propeptide of type III procollagen circulating levels in patients with chronic heart failure","volume":"10","author":"Cicoira","year":"2004","journal-title":"J Card Fail"},{"key":"R22-21-20210208","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0008-6363(03)00519-4","article-title":"Postischemic myocardial fibrosis occurs independent of hemodynamics changes","volume":"59","author":"Tsuda","year":"2003","journal-title":"Cardiovas Res"},{"key":"R23-21-20210208","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"R24-21-20210208","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/HJH.0b013e3282861fa4","article-title":"A possible association between primary aldosteronism and a lower (-cell function","volume":"25","author":"Mosso","year":"2007","journal-title":"J Hypertens"},{"key":"R25-21-20210208","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ki.1979.23","article-title":"Value of renin measurement, saralasin test, andacelretolol treatment in hypertension","volume":"15","author":"Kreft","year":"1979","journal-title":"Kidney Int"},{"key":"R26-21-20210208","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0002-9149(03)00543-5","article-title":"Relation between oxidative stress, catecholamines, and impaired chronotropic response to exercise in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"92","author":"Castro","year":"2003","journal-title":"Am J Cardiol"},{"key":"R27-21-20210208","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0014-5793(75)80385-1","article-title":"Malignant transformation-linked imbalance: decreased xanthine oxidase activity in hepatomas","volume":"59","author":"Prajda","year":"1975","journal-title":"FEBS Lett"},{"key":"R28-21-20210208","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.ehj.2003.09.022","article-title":"Correlation of oxidative stress with activity of matrix metalloproteinase in patients with coronary artery disease: possible role for left ventricular remodelling","volume":"24","author":"Kameda","year":"2003","journal-title":"Eur Heart J"},{"key":"R29-21-20210208","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1507\/endocrj.KR-80","article-title":"Aldosterone as a cardiovascular risk hormone","volume":"54","author":"Yoshimoto","year":"2007","journal-title":"Endocr J"},{"key":"R30-21-20210208","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.RES.86.5.494","article-title":"NAD(P)H oxidase role in cardiovascular biology and disease","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ Res"},{"key":"R31-21-20210208","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/hy1101.093423","article-title":"NADH\/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat","volume":"38","author":"Beswick","year":"2001","journal-title":"Hypertension"},{"key":"R32-21-20210208","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.107.710509","article-title":"Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study","volume":"116","author":"Pou","year":"2007","journal-title":"Circulation"},{"key":"R33-21-20210208","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijcard.2006.05.069","article-title":"Effect of spironolactone on C-reactive protein levels in patients with heart disease [letter].","volume":"117","author":"Godfrey","year":"2003","journal-title":"Int J Cardiol"},{"key":"R34-21-20210208","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/cvr\/cvn235","article-title":"Biochemical markers of myocardial remodelling in hypertensive heart disease.","volume":"81","author":"Gonzalez","year":"2009","journal-title":"Cardiovasc Res"},{"key":"R35-21-20210208","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/HYPERTENSIONAHA.109.141960","article-title":"Mitogen-activated protein kinases as biomarkers of hypertension or cardiac pressure overload","volume":"55","author":"Ocaranza","year":"2010","journal-title":"Hypertension"},{"key":"R36-21-20210208","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1152\/physrev.1999.79.1.215","article-title":"Molecular mechanism of myocardial remodeling","volume":"79","author":"Swynghedauw","year":"1999","journal-title":"Physiol Rev"},{"key":"R37-21-20210208","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitations of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"R38-21-20210208","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/01.hjh.0000173780.67308.f1","article-title":"The use of collagen-derived serum peptides for the clinical assessment of hypertensive heart disease","volume":"23","author":"L\u00f3pez","year":"2005","journal-title":"J Hypertens"},{"key":"R39-21-20210208","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/CIRCULATIONAHA.109.912774","article-title":"Circulating biomarkers of collagen metabolism in cardiac diseases","volume":"121","author":"L\u00f3pez","year":"2010","journal-title":"Circulation"},{"key":"R40-21-20210208","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/BF03346533","article-title":"Primary aldosteronism can alter peripheral levels of TGF- and TNF-.","volume":"32","author":"Carvajal","year":"2009","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004872-201010000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:32:02Z","timestamp":1786041122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-201010000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e32833d0177","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}